GlassScriptPhysician profile
Tod S Reed
NPI 1144211491
$862.99
in general payments reported to CMS, 2019-2025
11 companies · $446 in 2025
The $446 reported for 2025 was more than what a typical Foot Surgery provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $62.33 · 2020: $68.25 · 2022: $102 · 2023: $29.92 · 2024: $154 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $630.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $630.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $151.00 | 2022-2025 | Puraply Wound Matrix, Affinity |
| Smith+Nephew, INC. | $147.08 | 2019-2025 | Oasis, Grafix Pl, Collagenase Santyl |
| Stryker Corporation | $130.29 | 2019-2025 | Ortholoc 3di Crosscheck, Easyfuse |
| Kerecis Limited | $126.35 | 2023-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Depuy Synthes Sales INC. | $89.10 | 2020-2025 | Motoband |
| Hartmann USA, INC. | $58.06 | 2025 | Zetuvit Plus 10x10 P10 |
| Integra Lifesciences Corporation | $47.12 | 2019-2020 | |
| Globus Medical, INC. | $38.93 | 2025 | Senza |
| Ossur Americas, INC. | $28.78 | 2025 | |
| Tactile Systems Technology INC | $27.17 | 2020-2025 | Nimbl, Flexitouch Plus |
| Abbott Laboratories | $19.11 | 2024 | Proclaim |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tod Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.